Arrayjet’s ArrayPlex platform selected by Immunome for use in its discovery of targeted cancer therapies Post author: Post published:March 18, 2024 Post category:uncategorized Immunome signs deal to use Arrayjet platform in its in-house screening operations. You Might Also Like Are younger women experiencing a higher incidence of breast cancer? January 31, 2024 Neoadjuvant immunotherapy shows promise in multiple cancer types September 28, 2023 New research reveals how social isolation impacts behavior and lifespan in social species September 29, 2023
New research reveals how social isolation impacts behavior and lifespan in social species September 29, 2023